Price $28.27 |
Market Cap
3.08B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
18.1
|
P/B
2.89
|
P/S
0.47
|
Dividend %
3.40%
|
|
P/CF
340.0
|
P/FCF
-
|
Op. Cash Flow
-959.8K
|
FCF
-11.1
|
|
Op. Margin
1.90%
|
Net Margin
2.60%
|
ROE
16.80%
|
ROI
10.30%
|
|
ROA
6.00%
|
EPS Growth
133.90%
|
Current Ratio
1.5
|
Debt/Equity
50.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| LogicMark Inc (LGMK) | $1.13 | - | - | 12.5M | Strong Buy |
| Bimi International Medical Inc (BIMI) | $0.65 | - | - | 4.3M | Strong Buy |
| Lineage Cell Therapeutics Inc (LCTX) | $1.35 | - | - | 212.2M | Strong Buy |
| Endo International PLC (ENDP) | $0.39 | - | - | 124.1M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $0.65 | - | - | 22.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
